Current treatment of COVID-19 in renal patients: hope or hype?
- PMID: 32986137
- PMCID: PMC7520511
- DOI: 10.1007/s11739-020-02510-0
Current treatment of COVID-19 in renal patients: hope or hype?
Erratum in
-
Correction to: Current treatment of COVID-19 in renal patients: hope or hype?Intern Emerg Med. 2021 Jan;16(1):251. doi: 10.1007/s11739-020-02587-7. Intern Emerg Med. 2021. PMID: 33340347 Free PMC article. No abstract available.
Abstract
To date the severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), known as COVID-19, is for clinicians the most difficult global therapeutic problem. In this landscape, the management of patients with chronic kidney disease, acute kidney injury or patients undergoing immunosuppressant therapies for kidney transplant or glomerular diseases, represent a clinical challenge for nephrologists, especially in patients with severe acute lung involvement. Therefore in this setting, due to the lack of anti-COVID treatment schedules, tailored management is mandatory to reduce the side effects, as consequence of impaired renal function and drugs interactions. We report the main treatment actually used against SARS-CoV-2, underlining its possible use in the nephropatic patients and the central role of nephrologists to improve the clinical outcome.
Keywords: Antiviral therapy; COVID-19 treatment; Chronic kidney disease; Nephrology.
Conflict of interest statement
The author(s) declare that they have no conflict of interest.
References
-
- Alberici F, Del Barba E, Manenti C et al (2020) Gestione del paziente in dialisi e con trapianto di rene in corso di infezione da coronavirus Covid 19. Giornale Italiano di nefrologia Anno 37:2
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
